trial summary · NCT07477054
A Post-Approval Multicenter Study to Assess the Continued Safety and Effectiveness of the AeroPace® System
A Post-Approval Multicenter Study to Assess the Continued Safety and Effectiveness of the AeroPace® System - The AERO-PAS Study
Trial record from the TrialBase DB dataset, status RECRUITING, condition Ventilator Induced Diaphragm Dysfunction, sponsored by Lungpacer Medical Inc.. Facts below are exported values from the current release, not inferred or edited prose.
Summary
The brief summary is the registry's published description, capped for length. Field definitions, types, and provenance rules are in the data dictionary.
A single-arm, prospective, multicenter cohort study to assess the 30-day continued safety and effectiveness of the AeroPace System in patients on mechanical ventilation (MV) at least 96 hours and who have not weaned. This is a study collecting real-world data in a post-market setting.
Source record: https://clinicaltrials.gov/study/NCT07477054
Facts
| registry id | NCT07477054 |
|---|---|
| primary registry | clinicaltrials-gov |
| recruitment status | RECRUITING |
| phase | not reported |
| study type | INTERVENTIONAL |
| lead condition | Ventilator Induced Diaphragm Dysfunction |
| sponsor | Lungpacer Medical Inc. |
| sponsor class | INDUSTRY |
| enrollment | 120 |
| start date | 2026-10-31 |
| primary completion | 2028-08-31 |
| completion | 2028-09-30 |
| results posted | not reported |
Conditions
- Ventilator Induced Diaphragm Dysfunction
Interventions
- Lungpacer Diaphragm Pacing Therapy
Countries
- United States
Intervention types: DEVICE
Work with this record
- Field definitions
Types, scope, and provenance rules for every exported field.
- REST API
Query the same gate-backed records programmatically.
- Evaluation sample
Download a bounded slice before buying.
- $29 API Pass
Seven days of REST and MCP access; credited toward the licence.